Geistlich BioOss
Total Payments
$111,855
Transactions
3
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $70,795 | 2 | 0 |
| 2023 | $41,060 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $111,855 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A 4-arm randomized controlled trial of wound healing following tooth extraction and ridge preservation using DFDBA alone in particulate or fiber form, and in combinations with xenograft | Geistlich Pharma, North America, Inc. | $71,855 | 0 |
| Prospective, comparative assessment of alveolar preservation using Vallomix (TBA) in atraumatic extraction socket | Geistlich Pharma, North America, Inc. | $40,000 | 0 |
Top Doctors Receiving Payments for Geistlich BioOss
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | San Antonio, TX | $111,855 | 3 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $111,855
- Total Doctors 0
- Transactions 3
About Geistlich BioOss
Geistlich BioOss is a device associated with $111,855 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Geistlich Pharma, North America, Inc..
Payment data is available from 2023 to 2024. In 2024, $70,795 was paid across 2 transactions to 0 doctors.
The most common payment nature for Geistlich BioOss is "Unspecified" ($111,855, 100.0% of total).
Geistlich BioOss is associated with 2 research studies, including "A 4-arm randomized controlled trial of wound healing following tooth extraction and ridge preservation using DFDBA alone in particulate or fiber form, and in combinations with xenograft" ($71,855).